This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pal, T. Articles by Sutphen, R. Search for Related Content PubMed PubMed Citation Articles by Pal, T. Articles by Sutphen, R.

BRCA1 and BRCA2 Mutations in a Study of African American Breast Cancer Patients

¹ H. Lee Moffitt Cancer Center and Research Institute, and ² Department of Interdisciplinary Oncology, College of Medicine, University of South Florida, Tampa, Florida; and ³ All Children's Hospital, Department of Pediatrics, College of Medicine, University of South Florida, St. Petersburg, Florida

Requests for reprints: Jenny Permuth-Wey, Lifetime Cancer Screening and Prevention Center, H. Lee Moffitt Cancer Center and Research Institute, 4117 East Fowler Avenue, Tampa, FL 33617. Phone: 813-979-6770; Fax: 813-558-4807. E-mail: permutjm{at}moffitt.usf.edu

The spectrum of mutations in BRCA1 and BRCA2 among African Americans has not been well characterized because most studies to date have been done in Caucasian families. According to Myriad Genetic Laboratories, Inc., only 3% of individuals undergoing BRCA1/BRCA2 testing reported African American ancestry. Data from previous studies show that among African American women a greater proportion of breast cancer cases are diagnosed at age <45 years in comparison with Caucasians. Because breast cancer occurring at a young age is one of the hallmarks of high penetrance genes, the prevalence, spectrum, and effects of BRCA1/BRCA2 mutations may differ substantially between African Americans and Caucasians, and further investigation is warranted.

We conducted a hospital-based study of African American breast cancer patients with early age at diagnosis (45 years) or family history of breast or ovarian cancer. We identified four deleterious mutations in BRCA1 or BRCA2 among the 10 families tested, of which two were novel BRCA2 mutations, one was the west African founder mutation (BRCA1 943ins10), and one was a recurrent mutation that may be a candidate for a second African American founder mutation (BRCA1 IVS13+1G>A). Our results support previous data in demonstrating that (a) the spectrum of mutations among African Americans is unique, (b) family history of breast cancer is an important predictor of hereditary cancer susceptibility among African Americans, and (c) empirical data may be useful in estimating mutation risk among African Americans.

This article has been cited by other articles:

				E. M. John, A. Miron, G. Gong, A. I. Phipps, A. Felberg, F. P. Li, D. W. West, and A. S. Whittemore Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups JAMA, December 26, 2007; 298(24): 2869 - 2876. [Abstract] [Full Text] [PDF]

				K. E. Malone, J. R. Daling, D. R. Doody, L. Hsu, L. Bernstein, R. J. Coates, P. A. Marchbanks, M. S. Simon, J. A. McDonald, S. A. Norman, et al. Prevalence and Predictors of BRCA1 and BRCA2 Mutations in a Population-Based Study of Breast Cancer in White and Black American Women Ages 35 to 64 Years Cancer Res., August 15, 2006; 66(16): 8297 - 8308. [Abstract] [Full Text] [PDF]

				M. J. Hall and O. I. Olopade Disparities in Genetic Testing: Thinking Outside the BRCA Box J. Clin. Oncol., May 10, 2006; 24(14): 2197 - 2203. [Abstract] [Full Text] [PDF]

				B G Haffty, A Silber, E Matloff, J Chung, and D Lannin Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women J. Med. Genet., February 1, 2006; 43(2): 133 - 137. [Abstract] [Full Text] [PDF]